一圖看懂弘陽地產(01996.HK)2020年中期業績
作者:匯圖

格隆匯APP獲悉,8月26日,弘陽地產(01996.HK)公佈了2020年中期業績。上半年集團實現收入96.24億元人民幣(單位下同),同比增長146.3%;毛利24.34億元,同比增長115.0%;核心淨利潤8.74億元,同比增長80.7%;母公司擁有人應占核心淨利潤6.57億元,同比增長30.7%。
報告期內,實現合約銷售金額達15.7億元,同比上升4.4%。簽約均價由2019年同期的12889元每平方米上升至2020年上半年的14642元每平方米,同比上升13.6%。於2020年6月30日,集團土地儲備總建築面積約為1837.4萬平方米。具體業績如何,將以一圖為您展示。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.